The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period.

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs

Read the full report: https://www.reportlinker.com/p05605442

The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 85 tables and 103 figures– all unavailable elsewhere.
The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
- Cell-based Assays market forecasts from 2018-2028

Cell-Based Assays Market by Product Type:
- Instrument
- Consumables
- Software
- Services
- Reagents
- Assay Kits
- Microplates
- Cell Lines
- Probes & Labels

Cell-Based Assays Market by Application:
- Drug Discovery
- Basic Research
- Predictive Technology

Cell-based Assays Market by End-User:
- Pharma & Biotech Companies
- Academic Institutes
- CROs

This report provides individual revenue forecasts to 2028 for these national markets:
- US
- Japan
- Germany
- UK
- France
- Spain
- Italy
- China
- India
- Russia
- Brazil
- Our study includes SWOT and STEP analysis of the cell-based assays market.

Our study discusses the selected leading companies that are the major players in the cell-based assays market:
- BD (Becton, Dickinson and Company)
- BioAgilytix Labs
- BioVision
- Cell Assay Innovations, Inc.
- Charles River Laboratories International
- CYTOO SA
- DiscoverX
- GE Healthcare
- InSphero
- Marin Biological Laboratories
- Molecular Devices
- Perkin Elmer
- Pharmaceutical Product Development
- Porsolt
- Promega
- ProQinase GmbH
- QGel
- SGS Group, Inc.
- Thermo Fisher Scientific (and Affymetrix acquisition)
- This report also discusses technology, trends and future outlook of the cell-based assays industry

Read the full report: https://www.reportlinker.com/p05605442

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/the-revenue-of-the-cell-based-assays-market-in-2017-is-estimated-at-13bn-and-is-expected-to-grow-at-a-cagr-of-9-2-in-the-first-half-of-the-forecast-period-300742326.html

SOURCE Reportlinker